Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment-Reference-Cited by-同舟云学术

Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment

Published:2017-05-18 Issue:1 Volume:80 Page:29-36
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Abou-Alfa Ghassan K.,Lewis Lionel D.,LoRusso Patricia,Maitland Michael,Chandra Priya,Cheeti Sravanthi,Colburn Dawn,Williams Sarah,Simmons Brian,Graham Richard A.

Funder

Roche

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3315-8/fulltext.html

Reference17 articles.

1. Ingham PW, McMahon PW (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15:3059–3087

2. Di Magliano P, Hebrok M (2003) Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 3:903–911

3. Romer J, Curran T (2005) Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res 65:4975–4978

4. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, Nannini-Pepe M, Kotkow K, Marsters JC, Rubin LL, de Sauvage FJ (2008) A paracrine requirement for hedgehog signaling in cancer. Nature 455:406–410

5. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A (2012) Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 366:2171–2179

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy;MedComm;2024-02

2. Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma;Expert Review of Clinical Pharmacology;2023-11-23

3. Co‐targeting FAK and Gli1 inhibits the tumor‐associated macrophages‐released CCL22‐mediated esophageal squamous cell carcinoma malignancy;MedComm;2023-10-15

4. Hepatogenesis and hepatocarcinogenesis: Alignment of the main signaling pathways;Journal of Cellular Physiology;2022-08-29

5. Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment;Pharmacological Research;2022-05